FDA wants more info on female libido pill - FOX 8 WVUE New Orleans News, Weather, Sports, Social

FDA wants more info on female libido pill

AP Photo/Allen G. Breed AP Photo/Allen G. Breed

WASHINGTON (AP) - A drugmaker working to develop a pill to boost sexual desire in women says regulators are demanding more studies on the experimental drug.

Sprout Pharmaceuticals said Tuesday that the Food and Drug Administration wants to see more data on how the company's drug, flibanserin, interacts with other medications and how it affects driving ability. Nearly 10 percent of women studied in company trials reported sleepiness while taking the daily pill. The FDA's request represents another hurdle in the pharmaceutical industry's 15-year search for a female equivalent to Viagra.

But in a news release, Sprout Pharmaceuticals President Cindy Whitehead described the development as a "significant step toward the approval of flibanserin." The three studies requested by the FDA are relatively small, involving 25 to 50 patients each. The company says it plans to resubmit its drug application to FDA in the third quarter.

The company based in Raleigh, N.C., said in December that it had reached an "impasse" with regulators after the agency issued a second rejection letter on the drug. The company filed a formal dispute over the agency's decision, which prompted the FDA's latest request for additional studies.

If approved, Sprout's daily pill would be the first drug for women who report a lack of sexual desire, a market that drugmakers have been trying to tap since the blockbuster success of Viagra for men in the late 1990s. While earlier drugs worked on hormone levels, flibanserin is the first attempt to increase sexual desire by acting on brain chemicals that affect appetite and mood.

The race to develop a female libido booster was once dominated by multinational companies like Viagra-maker Pfizer Inc. and Procter & Gamble, but today the space mainly consists of tiny startups. Sprout Pharmaceuticals, led by a husband and wife team, acquired flibanserin from Boehringer Ingelheim in 2011, after the German conglomerate abandoned development following an FDA rejection letter. Boehringer studies showed that women taking the drug reported only a modest uptick in "sexually satisfying events."

The FDA's initial rejection followed a 2010 meeting where a panel of expert advisers unanimously voted against the drug, citing its lackluster effectiveness and side effects such as fatigue, dizziness and nausea. Even if the FDA eventually approves flibanserin, Sprout will have to convince doctors to prescribe the drug for a condition that is still viewed with some skepticism.

The drug would be specifically approved for premenopausal women with hypoactive sexual desire disorder, described as a lack of sexual appetite that causes emotional distress. Because so many factors affect female sexual appetite, there are a number of other possible causes doctors must rule out before diagnosing the condition, including relationship problems, hormone disorders, depression and mood issues caused by other drugs like sleeping aids and pain medications.

(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

 

  • Local NewsMore>>

  • Juan's World: Saints ground Jets, look to Falcons rematch

    Juan's World: Saints ground Jets, look to Falcons rematch

    The Saints meet up with the Falcons on Christmas Eve. Source: Mark LaGrangeThe Saints meet up with the Falcons on Christmas Eve. Source: Mark LaGrange

    Welcome in to Juan's World and as you know, this blog that I do is strictly an opinion piece with a few facts sprinkled in here and there. So, with that in mind, I'm under the opinion that the Saints should've been 'expected' to look past the Jets to next weeks rematch with the Falcons. How could they not look ahead to Atlanta coming to the dome next Sunday. And before you go all 'One Game at a Time' on me, think for a second. You're supposed to beat the Jets, who came in 5-8 and wi...

    more>>

    Welcome in to Juan's World and as you know, this blog that I do is strictly an opinion piece with a few facts sprinkled in here and there. So, with that in mind, I'm under the opinion that the Saints should've been 'expected' to look past the Jets to next weeks rematch with the Falcons. How could they not look ahead to Atlanta coming to the dome next Sunday. And before you go all 'One Game at a Time' on me, think for a second. You're supposed to beat the Jets, who came in 5-8 and wi...

    more>>
  • Brees recognizes too many missed opportunities in Jets game

    Brees recognizes too many missed opportunities in Jets game

    Brandon Coleman lost two fumbles in the Jets game. Source: Nola.comBrandon Coleman lost two fumbles in the Jets game. Source: Nola.com

    Three turnovers against the lowly Jets can still get you a win in this league. Numerous giveaways against the Eagles, Vikings, Rams, or Panthers might not give you the same result in the standings. The Saints end the season with the Falcons and the Bucs. If they want to end the 2017 regular season campaign on a win streak, things need to be cleaned up. "Two fumbles, and at times you're going to score. I just think that's happened too many times to us this year. We're knocking a...

    more>>

    Three turnovers against the lowly Jets can still get you a win in this league. Numerous giveaways against the Eagles, Vikings, Rams, or Panthers might not give you the same result in the standings. The Saints end the season with the Falcons and the Bucs. If they want to end the 2017 regular season campaign on a win streak, things need to be cleaned up. "Two fumbles, and at times you're going to score. I just think that's happened too many times to us this year. We're knocking a...

    more>>
  • I-10 East closed at Morrison Rd.

    I-10 East closed at Morrison Rd.

    Source: DOTDSource: DOTD

    I-10 East is closed at Morrison Road due to an accident. 

    more>>

    I-10 East is closed at Morrison Road due to an accident. 

    more>>
Powered by Frankly